Swan Hill District Health Vaccincation Program Update
Swan Hill District Health (SHDH) has provided the following important information relating to the SHDH Respiratory Clinic Vaccination program:
Swan Hill District Health has acted swiftly in line with the advice provided by the Australian Technical Advisory Group on Immunisation (ATAGI) in light of the evolving evidence of a rare but serious side effect involving thrombosis with thrombocytopenia following receipt of the AstraZeneca vaccine.
The ATAGI has recommended new changes to the Australian COVID-19 Vaccine Program including a preference for the use of the Pfizer vaccine in adults aged under 50 years.
The ATAGI has recommended that:
- The AstraZeneca vaccine should only be used in adults aged under 50 where the benefits clearly outweigh the risk for that individual and the person has made an informed decision based on an understanding of the risks and benefits.
- People who have had the first dose of COVID-19 Vaccine AstraZeneca without any serious adverse effects can be given the second dose, including adults under 50 years.